|
| About us |
| |
axxonis is a product-driven pharmaceutical company
with strong development potential and with
already established third parties agreements.
The qualifications in the research and manufacturing area of these third partners
complement axxonis expertise and enables axxonis to achieve the competitive
advantage in the field of neurodegenerative diseases.
axxonis acquires the rights to products or active pharmaceutical agents which
can be developed efficiently for other valuable applications and indications.
The strategy of product life cycle management allows a more cost and time efficient
way of advancing rapidly into late stage development and launch.
|
| |
Print:
|
|
|
